Summary of SRES 266: Designating May 2025 as "ALS Awareness Month"

Bill Overview

Bill Number: SRES 266

Title: A resolution designating May 2025 as "ALS Awareness Month"

Status: Introduced in Senate

Introduced Date: June 05, 2025

Classification: Resolution

Purpose and Intent

The primary purpose of SRES 266 is to officially designate May 2025 as "ALS Awareness Month." This resolution aims to raise awareness about amyotrophic lateral sclerosis (ALS), a progressive neurodegenerative disease that affects nerve cells in the brain and spinal cord. By establishing this month, the Senate seeks to highlight the challenges faced by individuals living with ALS and to promote efforts towards treatment, research, and support.

Key Provisions

The resolution includes several important affirmations and commitments by the Senate:

1. Designation of ALS Awareness Month:

   • May 2025 is officially recognized as ALS Awareness Month.

2. Commitments to ALS Patients:

   • The Senate affirms its dedication to:
     • Ensuring access to effective treatments and high-quality services for individuals diagnosed with ALS as early as possible.
     • Identifying risk factors and causes of ALS to help prevent new cases.
     • Empowering individuals with ALS to maintain their independence to the greatest extent possible.
     • Reducing the physical and emotional burdens associated with living with ALS.

3. Commendation of Supporters:

   • The resolution commends the efforts of family members, friends, organizations, volunteers, researchers, and caregivers who are dedicated to improving the quality of life for ALS patients and advancing research for effective treatments and cures.

Impact

The designation of May 2025 as ALS Awareness Month is expected to:
- Increase public awareness about ALS and its impact on individuals and families.
- Encourage discussions around the need for research funding and support services for ALS patients.
- Foster a sense of community and support among those affected by ALS, including patients, caregivers, and advocates.

Legislative Actions

• June 05, 2025: The resolution was submitted in the Senate, considered, and agreed to without amendment and with a preamble by Unanimous Consent.
• The resolution passed in the Senate on the same day it was introduced.

Sponsors

The resolution is sponsored by:
- Lisa Murkowski (Primary Sponsor)
- Christopher A. Coons (Cosponsor)
- Tom Cotton (Cosponsor)
- Sheldon Whitehouse (Cosponsor)

This resolution reflects a bipartisan commitment to raising awareness and supporting those affected by ALS, highlighting the importance of continued advocacy and research in the fight against this debilitating disease.